Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Roderick

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Plos One|August 9, 2018
The ICE-AKI study: Impact analysis of a Clinical prediction rule and Electronic AKI alert in general medical patientsLuke E Hodgson, Paul J Roderick, Richard M Venn, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 20, 2021
Treatment burden for patients with multimorbidity: cross-sectional study with exploration of a single-item measureJames E Morris, Paul J Roderick, Scott Harris, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
Exploring the differences in epidemiology of treated ESRD between Germany and England and WalesFergus J Caskey, Hans-Jürgen Schober-Halstenberg, Paul J Roderick, et al.
Plos One|May 29, 2014
Assessment of proteinuria in patients with chronic kidney disease stage 3: albuminuria and non-albumin proteinuriaSimon D S Fraser, Paul J Roderick, Natasha J McIntyre, et al.
American Journal of Public Health|May 31, 2008
Socioeconomic disadvantage and kidney disease in the United States, Australia, and ThailandSarah L White, Kevin McGeechan, Michael Jones, et al.
Kidney International Reports|May 20, 2021
Evaluation of Urinary Biomarkers of Proximal Tubular Injury, Inflammation, and Fibrosis in Patients With Albuminuric and Nonalbuminuric Diabetic Kidney DiseaseMysore K Phanish, Andrew N Chapman, Sarah Yates, et al.
Age and Ageing|April 29, 2026
Projected trends in frailty prevalence and associated health service use and costs in the over-50s in England, 2025 to 2040: a simulation modelling studyBronagh Walsh, Tracey England, Sally Brailsford, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 1, 2011
Inequalities in rates of renal replacement therapy in England: does it matter who you are or where you live?Andy Judge, Fergus J Caskey, Nicky J Welton, et al.
BMC Nephrology|December 10, 2017
Prevalence and related risk factors of chronic kidney disease among adults in Luxembourg: evidence from the observation of cardiovascular risk factors (ORISCAV-LUX) studyAla'a Alkerwi, Nicolas Sauvageot, Illiasse El Bahi, et al.
Plos One|February 21, 2015
Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for EnglandSimon D S Fraser, Grant Aitken, Maarten W Taal, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Plos One|August 9, 2018
The ICE-AKI study: Impact analysis of a Clinical prediction rule and Electronic AKI alert in general medical patientsLuke E Hodgson, Paul J Roderick, Richard M Venn, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|April 20, 2021
Treatment burden for patients with multimorbidity: cross-sectional study with exploration of a single-item measureJames E Morris, Paul J Roderick, Scott Harris, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 24, 2006
Exploring the differences in epidemiology of treated ESRD between Germany and England and WalesFergus J Caskey, Hans-Jürgen Schober-Halstenberg, Paul J Roderick, et al.
Plos One|May 29, 2014
Assessment of proteinuria in patients with chronic kidney disease stage 3: albuminuria and non-albumin proteinuriaSimon D S Fraser, Paul J Roderick, Natasha J McIntyre, et al.
American Journal of Public Health|May 31, 2008
Socioeconomic disadvantage and kidney disease in the United States, Australia, and ThailandSarah L White, Kevin McGeechan, Michael Jones, et al.
Kidney International Reports|May 20, 2021
Evaluation of Urinary Biomarkers of Proximal Tubular Injury, Inflammation, and Fibrosis in Patients With Albuminuric and Nonalbuminuric Diabetic Kidney DiseaseMysore K Phanish, Andrew N Chapman, Sarah Yates, et al.
Age and Ageing|April 29, 2026
Projected trends in frailty prevalence and associated health service use and costs in the over-50s in England, 2025 to 2040: a simulation modelling studyBronagh Walsh, Tracey England, Sally Brailsford, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 1, 2011
Inequalities in rates of renal replacement therapy in England: does it matter who you are or where you live?Andy Judge, Fergus J Caskey, Nicky J Welton, et al.
BMC Nephrology|December 10, 2017
Prevalence and related risk factors of chronic kidney disease among adults in Luxembourg: evidence from the observation of cardiovascular risk factors (ORISCAV-LUX) studyAla'a Alkerwi, Nicolas Sauvageot, Illiasse El Bahi, et al.
Plos One|February 21, 2015
Exploration of chronic kidney disease prevalence estimates using new measures of kidney function in the health survey for EnglandSimon D S Fraser, Grant Aitken, Maarten W Taal, et al.
Pageof 9